| Title: |
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole |
| Authors: |
Fasching, Peter A. a, ⁎, 1; Hack, Carolin C. a, 1; Nabieva, Naiba a; Maass, Nicolai b; Aktas, Bahriye c; Kümmel, Sherko d; Thomssen, Christoph e; Wolf, Christopher f; Kolberg, Hans-Christian g; Brucker, Cosima h; Janni, Wolfgang i; Dall, Peter j; Schneeweiss, Andreas k; Marme, Frederik l; Sütterlin, Marc W. l; Ruebner, Matthias a; Theuser, Anna-Katharin m; Kellner, Sara a; Hofmann, Nadine M. m; Böhm, Sybille m; Almstedt, Katrin a, n; Lück, Hans-Joachim o; Schmatloch, Sabine p; Kalder, Matthias q; Uleer, Christoph r; Jurhasz-Böss, Ingolf s; Hanf, Volker t; Jackisch, Christian u; Müller, Volkmar v; Rack, Brigitte i; Belleville, Erik w; Wallwiener, Diethelm x; Rody, Achim y; Rauh, Claudia a, z; Bayer, Christian M. a, aa; Uhrig, Sabrina a; Goossens, Chloë a; Huebner, Hanna a; Brucker, Sara Y. x; Hein, Alexander ab; Fehm, Tanja N. ac, ad; Häberle, Lothar a, ae |
| Source: |
In European Journal of Cancer September 2024 209 |
| Database: |
ScienceDirect |